Thalys Medical Technology Group Corporation (SHA:603716)

China · Delayed Price · Currency is CNY

14.38

-1.52 (-9.56%)

Jul 21, 2026, 1:00 PM CST

-39.32% (1Y)

Market Cap	3.40B -23.2%
Revenue (ttm)	971.32M -39.8%
Net Income	-210.48M
EPS	-1.04
Shares Out	214.11M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,766,814
Open	15.22
Previous Close	15.90
Day's Range	14.31 - 15.28
52-Week Range	12.92 - 38.12
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2004

Employees 1,045

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 603716

Full Company Profile

Financial Performance

In 2025, SHA:603716's revenue was 1.08 billion, a decrease of -40.52% compared to the previous year's 1.81 billion. Losses were -207.28 million, -0.93% less than in 2024.

Financial Statements